Clinical Trial Design Agenda
Thursday, December 10th, 2020
- How is the industry reacting to this shift in leveraging remote strategies?
- How do we balance key factors such as patient centricity, data, regulation, compliance and cost, and should flexibility be the greatest priority?
- What impact is this having on the regulators and how they operate?
- Will remote trials affect data endpoints and to what extent?
- What impact do virtual, decentralised and hybrid trials have on patients and how can we reduce potential burdens?
- How is this influencing patient engagement strategies?